ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 33767971

Systemic adverse effects and toxicities associated with immunotherapy: A review.

Kichloo A and 9 others. World J Clin Oncol, 2021. Cited by 84 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Systemic adverse effects and toxicities associated with immunotherapy: A review. Papers, record 33767971. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33767971

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Systemic adverse effects and toxicities associated with immunotherapy: A review.
PubMed
Journal
World J Clin Oncol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
84
iCite
Relative citation ratio, by iCite
4.73
iCite
Revised in PubMed
2021-03-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kichloo AAsim
2Albosta MMichael
3Dahiya DDushyant
4Guidi JCJean Claude
5Aljadah MMichael
6Singh JJagmeet
7Shaka HHafeez
8Wani FFarah
9Kumar AAkshay
10Lekkala MManidhar

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References56

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,962,976Cardiotoxicity of anticancer treatments.Nat Rev Cardiol2015https://conductscience.org/library/papers/25962976PubMed
224,858,820Bevacizumab increases the risk of gastrointestinal perforation in cancer patients: a meta-analysis with a focus on different subgroups.Eur J Clin Pharmacol2014https://conductscience.org/library/papers/24858820PubMed
330,939,947Hypophysitis in the era of immune checkpoint inhibitors and immunoglobulin G4-related disease.Expert Rev Endocrinol Metab2019https://conductscience.org/library/papers/30939947PubMed
423,447,136Multifocal radiculoneuropathy during ipilimumab treatment of melanoma.Muscle Nerve2013https://conductscience.org/library/papers/23447136PubMed
531,679,184Immune checkpoint inhibitor-associated pituitary-adrenal dysfunction: A systematic review and meta-analysis.Cancer Med2019https://conductscience.org/library/papers/31679184PubMed
631,587,780Cardiotoxicity of Immune Therapy.Cardiol Clin2019https://conductscience.org/library/papers/31587780PubMed
729,143,108Immune checkpoint inhibitor colitis: the flip side of the wonder drugs.Virchows Arch2018https://conductscience.org/library/papers/29143108PubMed
829,875,199Cancer immunotherapy: broadening the scope of targetable tumours.Open Biol2018https://conductscience.org/library/papers/29875199PubMed
920,728,210
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
Lancet2010https://conductscience.org/library/papers/20728210PubMed
1029,955,867Programmed Cell Death-1 Inhibitor-Induced Type 1 Diabetes Mellitus.J Clin Endocrinol Metab2018https://conductscience.org/library/papers/29955867PubMed

1 to 10 of 56

See all 56 references

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 84 citations.

PMIDTitleJournalYearIn PapersSource
42,848,401Development and Validation of a Tool to Measure Documented Health Care Encounter Time.JAMA Netw Open2026https://conductscience.org/library/papers/42848401PubMed
42,764,918Artificial "zombie" cells: An emerging platform for targeted drug delivery and disease treatment.Acta Pharm Sin B2026https://conductscience.org/library/papers/42764918PubMed
42,563,266Nanomaterial Strategies for Pulmonary Delivery of Immunotherapeutics in Lung Cancer Treatment.Adv Healthc Mater2026https://conductscience.org/library/papers/42563266PubMed
42,352,417Emerging Perspectives on Adverse Childhood Experiences and Brain Cancer Immunotherapy.Cancers (Basel)2026https://conductscience.org/library/papers/42352417PubMed
42,255,146Therapeutic exosomes in cancer: efficacy and safety perspectives.RSC Adv2026https://conductscience.org/library/papers/42255146PubMed
42,095,302Nanotechnology Meets Immunotherapy: Crosstalks Against Cancer.Immun Inflamm Dis2026https://conductscience.org/library/papers/42095302PubMed
42,035,192CD8 immunoPET imaging to stratify response and guide combination immunotherapy and radiation in triple negative breast cancer.Breast Cancer Res2026https://conductscience.org/library/papers/42035192PubMed
41,939,014Vaginal mucosal melanoma recurrence with intracardiac metastasis treated with immunotherapy.Gynecol Oncol Rep2026https://conductscience.org/library/papers/41939014PubMed
41,901,151Dietary and Nutritional Strategies for Patients with Glioma: A Narrative Review of Treatment, Recovery, Immune Support, and Microbiota Modulation.Nutrients2026https://conductscience.org/library/papers/41901151PubMed
41,817,408The lethal symbiont: exploring the pathophysiology of cancer.Physiol Rev2026https://conductscience.org/library/papers/41817408PubMed

1 to 10 of 62

See all 62 cited by

Genes43

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABL125PubTator's text mininghttps://conductscience.org/library/genes/25NCBI Gene
ALK238PubTator's text mininghttps://conductscience.org/library/genes/238NCBI Gene
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
CD14929PubTator's text mininghttps://conductscience.org/library/genes/929NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD38952PubTator's text mininghttps://conductscience.org/library/genes/952NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene

1 to 10 of 43

See all 43 genes

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33767971

GET https://conductscience.org/api/papers/v1/33767971/references?page=2

API referenceFor AI assistants